Health and Care Research Wales – Bulletin
Over £18 million has been invested in NHS research in Wales, while major findings from the SOUL trial show semaglutide could reduce heart attack risk in people with type 2 diabetes. New funding opportunities, upcoming events, and career news are also featured in this recent Health and Care Research Wales e-bulletin.
For full updates and to access the e-bulletin, follow the link here.